This may have been due to improved health and, consequently, better iron absorption in our study population, as the ECCO guidelines recommend oral iron supplementation only for IBD patients with normal C-reactive protein levels and mild IDA who are in clinical remission. Here, CRP is linked to inflammatory bowel disease.